Microsoft word - 110711_ ecp-renova announcement_final

ECP and Renova will jointly develop and acquire renewable projects through Centennial
Short Hills, New Jersey and Denver, Colorado – July 11, 2011 -- Energy Capital
Partners today announced the formation of Centennial Renewable Power, LLC, a
subsidiary of Energy Capital Partners II, LP, and a partnership with Renova Capital
Partners to jointly develop and acquire renewable power projects.
With the formation of Centennial, ECP is seeking to invest up to $250 million of equity in
renewable projects over the next three years to create a leading diversified renewable
power company. Centennial’s initial focus will be on acquiring and developing
geothermal, biomass, waste-to-energy (including landfill gas) and solar assets.
Renova, a founder and major shareholder of solar developer Main Street Power, is
contributing its pipeline of projects in development which will provide Centennial initial
and on-going investment opportunities. Centennial will seek to partner with developers on
well positioned renewable projects that otherwise do not have adequate access to capital or
economies of scale to come to successful fruition. ECP will fund Centennial’s renewable
energy platform on a project-by-project basis. Centennial will also look to acquire
operating assets and fund projects already in advanced stages of development.
Rahul Advani, a principal at ECP, said, “We are very excited about the formation of
Centennial and the new partnership with Renova, which we believe will enable us to
provide needed strategic capital to the renewable power sector.” He added, “the
relationship with Renova’s impressive team complements ECP’s existing capabilities and
expands our breadth and depth in the renewable sector.”
Phil Caplan, Bob Doherty and Rick Tallman, the founding partners of Renova said , “We
are delighted to have established this partnership with Energy Capital. Their investment
team and track record are world-class, and we look forward to providing critically-needed
capital in an underserved market. This partnership will enable us to expand our pipeline
and relationships with our on-the-ground development partners.”

About Energy Capital Partners
ECP is a private equity firm focused on investing in the power generation, midstream gas,
renewable and electric transmission sectors of energy infrastructure. ECP's management
has substantial experience leading successful energy companies and energy infrastructure
investments, including in the renewable sector. ECP has offices in Short Hills, New Jersey
and San Diego, California. For more information, visit
About Renova Capital Partners
Renova Capital is a Denver-based private investment partnership founded in 2007 to
finance, develop, own and aggregate middle-market renewable energy infrastructure assets.
Renova is focused on projects that generate clean, inexpensive and reliable base load
power. Renova partners with best-in-class developers by leveraging in-house resources and
capital with their project development experience and technical expertise. For more
information, visit




Effect of dietary willow herb, epilobium hirsutum extract on growth performance, body composition, haematological parameters and aeromonas hydrophila challenge on common carp, cyprinus carpio

Effect of dietary willow herb, Epilobium hirsutumextract on growth performance, body composition,hydrophila challenge on common carp, Cyprinus carpioSomayeh Pakravan, Abdolmajid Hajimoradloo & Rasool GhorbaniFisheries Department, Gorgan University of Agricultural Sciences and Natural Resources, Gorgan, IranCorrespondence: A Hajimoradloo, Fisheries Department, Gorgan University of Ag

Microsoft word - abstract_vol_3_01_.doc

HÉMA-VIGIE…always on the lookout! A Monthly Newsletter Summarizing Important Advances in Transfusion Volume 3, Number 1 West Nile virus – infected birds: an early tral role in the peripheral circulation problems commonly warning sign of upcoming human infec- encountered in sickle-cell disease patients. Reiter, C. D., et al. (2002). Cell-free hemoglobin limits nit

Copyright © 2011-2018 Health Abstracts